Wall Street Analyst Upgrades to Watch Today

 TopRated
 
  TopRated
 
Follow  Message
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  27 Aug 2026
 

$MAA Mid-America Apartment Communities remains a Buy at Truist, although the firm trimmed its price target to $142 from $146 rather than issuing a fresh rating upgrade. The analyst view reflects a mixed setup: apartment fundamentals remain investable, but near-term labor market softness could pressure demand. At $128.79, the stock is trading below the revised target, but the catalyst is less aggressive than the other names because the rating itself did not change.

$JOB GEE Group was upgraded to Neutral as improving profitability, a stronger direct-hire revenue mix and solid liquidity began to offset weakness in contract staffing. The upgrade is notable because it reflects improving business quality rather than a simple valuation call. At $0.25, however, the uncertain hiring environment continues to cap visibility, making this more of a stabilization signal than a clean near-term rerating setup.

$MSCI MSCI was upgraded to Buy with the shares trading around $569.15 and a listed target of $584.11, implying approximately 2.8% upside. The setup is less about deep valuation dislocation and more about improving confidence in the underlying business. With the stock already relatively close to the stated target, the upgrade provides incremental support but limited immediate price asymmetry.

$RIVN Rivian received the clearest conventional upgrade in the group, with TD Cowen moving the stock from Hold to Buy and raising its target from $17 to $20. The call is built around proprietary demand work for the R2 SUV, with full-scale annual volume estimated at 212,000 to 335,000 units, above what the broader analyst community is modeling for 2027. With the stock around $16.86 and down roughly 17.2% year to date, the upgrade argues that the recent selloff has improved the risk-reward profile. The important catalyst is whether R2 demand converts from forecasted interest into production scale and delivery momentum.

$GGG Graco was upgraded to a Zacks Rank #2 Buy as earnings estimate trends improved. The stock was trading near $79.62 against a listed target of $83.54, leaving roughly 5.5% upside. This is a more measured setup than Rivian because the thesis rests on improving earnings expectations rather than a major company-specific product catalyst. The upgrade supports the stock, but the current target leaves relatively modest room for near-term multiple expansion.

$AMD Advanced Micro Devices was upgraded to Strong Buy, although the supplied data show a current price of $476.67 against a $465 target, placing the target roughly 2% below the market price. That disconnect matters because the rating is more constructive than the valuation implied by the listed target. The signal therefore points to confidence in the earnings and AI growth trajectory, but the near-term price setup is less compelling unless estimates or targets move higher. Traders should distinguish between a bullish rating change and actual upside embedded in the current target framework.

$DSGN Design Therapeutics remained rated Outperform at RBC Capital while its target increased to $14 from $13, so this is a target raise rather than a true rating upgrade. The investment case centers on pipeline progress and expected data readouts in the second half of 2026. At $15.25, however, the shares are already above the new $14 target shown in the source data, which limits the immediate valuation case despite the constructive clinical outlook. The catalyst remains binary and pipeline-driven rather than based on near-term earnings acceleration.

Bottom line - Rivian offers the most attractive near-term opportunity in this group because it combines an actual rating upgrade, a higher price target and a specific operating catalyst in the R2 launch. The analyst demand estimates also sit above broader 2027 expectations, creating the clearest potential gap between consensus assumptions and company execution. Graco offers a cleaner but lower-upside earnings revision setup, while AMD carries the strongest rating language but lacks support from the listed target at the current price.

View all market intelligence